AVDL
Avadel Pharmaceuticals
NASDAQ · Pharmaceuticals
$21.69
+0.09 (+0.42%)
Performance
1D
—
1W
+0.60%
1M
+0.88%
3M
+15.19%
6M
+57.52%
1Y
+138.61%
YTD
+0.79%
Open$21.60
Previous Close$21.60
Day High$21.70
Day Low$21.59
52W High$23.57
52W Low$6.38
Volume1.08M
Avg Volume1.01M
Market Cap2.12B
P/E Ratio—
EPS$-0.01
SectorPharmaceuticals
Volume Analysis
1.07x average volume
Technical Indicators
SMA 50
$21.52
Above
SMA 200
$15.23
Above
RSI (14)
78.4
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
16 analysts
Price Target
+436.1% upside
Current
$21.69
$21.69
Target
$116.27
$116.27
$84.09
$116.27 avg
$133.85
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 173.87M | 88.54M | 349.90M |
| Net Income | -50,209,770 | -23,012,065 | 87.87M |
| Profit Margin | -28.9% | -27.4% | 25.1% |
| EBITDA | -36,564,216 | -17,689,059 | 157.77M |
| Free Cash Flow | — | — | 68.00M |
| Rev Growth | +96.4% | +96.4% | +15.0% |
| Debt/Equity | 0.48 | 0.48 | 0.62 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |